Showing results (11-20 of 102) with videos related to
Sort By:
Pageof 11
International Journal of Clinical Practice. Supplement|May 17, 2002
Community-acquired lower respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitorsHartmut LodeArchives of Toxicology|June 18, 2003
Ultrastructural changes induced by the des-F(6)-quinolone garenoxacin (BMS-284756) and two fluoroquinolones in Achilles tendon from immature ratsMehdi Shakibaei, Ralf StahlmannMedizinische Monatsschrift Fur Pharmazeuten|February 2, 2013
[The eye as target of adverse ocular drug reactions. Focus on systemic antiinfective therapy]Matthias Huber, Ralf StahlmannMedizinische Monatsschrift Fur Pharmazeuten|November 5, 2009
[Nephrogenic systemic fibrosis]Astrid Breitschaft, Ralf StahlmannGerman Medical Science : GMS E-Journal|July 22, 2015
Risks, risk assessment and risk competence in toxicologyRalf Stahlmann, Aniko HorvathMedizinische Monatsschrift Fur Pharmazeuten|June 30, 2007
[Chloracne after exposure to dioxin]Florian Pape, Ralf StahlmannArchives of Toxicology|April 6, 2004
Developmental toxicity of polychlorinated biphenyls (PCBs): a systematic review of experimental dataBeate Ulbrich, Ralf StahlmannArchives of Toxicology|October 27, 2009
Use of two validated in vitro tests to assess the embryotoxic potential of mycophenolic acidKathrin Eckardt, Ralf StahlmannExpert Opinion on Pharmacotherapy|March 25, 2006
Drug interactions during therapy with three major groups of antimicrobial agentsKasra Shakeri-Nejad, Ralf StahlmannExpert Opinion on Drug Safety|May 9, 2013
Risks associated with the therapeutic use of fluoroquinolonesRalf Stahlmann, Hartmut M LodePageof 11